Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

bendroflumethiazide-nadolol

bendroflumethiazide-nadolol
  • Non-formulary
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Corzide TABLET, ORAL 5 mg-40 mg    


Comments:

Ordered Formulation

Therapeutic Interchange

bendroflumethiazide-nadolol (Corzide)

  • 5 mg-40 mg tablet oral

hydrochlorothiazide (HydroDIURIL) AND propranolol LA (Inderal LA)

  • ONE 50 mg hydrochlorothiazide tablet PLUS ONE 60 mg propranolol LA tablet

Last updated: Dec. 12, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.